Platypus venom inspires potential new diabetes treatments

June 14, 2018 by Robyn Mills, University of Adelaide
Credit: CC0 Public Domain

The world-first discovery of a key metabolic hormone found in the venom and gut of Australia's iconic platypus will now be investigated for its potential to treat type 2 diabetes, in new research led by the University of Adelaide.

In a collaboration between the University of Adelaide, Flinders University, Monash University, SAHMRI and the Royal Adelaide Hospital, funding from Medvet Science is supporting a study to investigate whether the platypus hormone could be more effective and sustained in action than current medication.

The discovery stems from the sequencing of the platypus genome in 2008. Project leader Professor Frank Grutzner, from the University of Adelaide, was a member of that team and is considered an authority on monotreme genetics.

The metabolic hormone is known as glucagon-like peptide-1 (GLP-1), and is normally secreted in the gut of both humans and , stimulating the release of insulin to lower blood glucose. A modified form of GLP-1, exenatide, is widely used for diabetes treatment.

"One of the most amazing discoveries of the platypus genome project was the massive loss of genes important for digestion and metabolic control – these animals basically lack a functional stomach," Professor Grutzner says. "More recently we discovered that monotreme GLP-1 has changed radically in these animals, due to its dual function in both the gut and venom."

Numerous research groups worldwide are investigating different forms of GLP-1 for their effects on metabolic diseases, including diabetes.

"We have privileged access to these amazing animals," says Professor Grutzner. "Male platypuses produce venom during the breeding season, and can deliver the venom from their hind spurs. We were surprised to see GLP-1 present in and think that this may have led to a more effective hormone.

"We already know that their GLP-1 works differently, and is more resistant to the rapid degradation normally seen in humans. Maybe this iconic Australian animal holds the answer to a more effective and safer management option for including diabetes."

The effects of platypus-derived GLP-1 are now being explored in detail thanks to a $200,000 grant from Medvet Science, the medical research support and commercialisation arm of the Central Adelaide Local Health Network. Medvet Science works on behalf of several hospitals in Adelaide to commercialise medical inventions.

"This discovery has the potential to produce significant benefits for human health by bringing industry, leading academic researchers and clinical expertise together," said Medvet Science's Managing Director and CEO, Mr Greg Johansen.

"This is the first step towards testing the clinical relevance of platypus GLP-1. We believe it's a project with great commercial potential and an example of the world-class research being conducted right here in South Australia," Mr Johansen said.

Explore further: Scientists find new genes on male sex chromosomes

Related Stories

Scientists find new genes on male sex chromosomes

April 24, 2014
Scientists are a step closer to discovering what determines the sex of Australia's iconic platypus and echidna, after an international study involving researchers from the University of Adelaide and UNSW Australia unravelled ...

Recommended for you

Possible link found between diabetes and common white pigment

June 20, 2018
In a pilot study by a team of researchers at The University of Texas at Austin, crystalline particles of titanium dioxide—the most common white pigment in everyday products ranging from paint to candies—were found in ...

Diagnosing diabetes from a single blood sample

June 18, 2018
Diagnosing type 2 diabetes in clinical practice may require only a single blood sample, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health.

Lentils significantly reduce blood glucose levels, study reveals

June 13, 2018
Replacing potatoes or rice with pulses can lower your blood glucose levels by more than 20 per cent, according to a first-ever University of Guelph study.

Is there a link between diabetes and Parkinson's disease?

June 13, 2018
People with type 2 diabetes may have an increased risk of having a diagnosis of Parkinson's disease later in life, according to a large study published in the June 13, 2018, online issue of Neurology, the medical journal ...

Double-checking diabetes medications may reduce re-hospitalizations

June 11, 2018
Clinicians may take upwards of 15 minutes to double-check a patient's medication list in an electronic health record system, but according to a new study, this reconciliation process may be well worth the time for diabetes ...

How a gene linked to obesity could provide new insights into diabetes

June 8, 2018
A gene previously linked with obesity has been found to affect how the body processes insulin, with potential implications for some forms of diabetes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.